Role of Pattern Recognition Receptors of the Neurovascular Unit in Inflamm-Aging by Wilhelm, Imola Mária et al.
Role of Pattern Recognition Receptors of the Neurovascular Unit in Inflamm-Aging 1 
 2 
Imola Wilhelm
1,2*
, Ádám Nyúl-Tóth
1
, Mihály Kozma
1
, Attila E. Farkas
1
, István A. Krizbai
1,2
 3 
 4 
1
Institute of Biophysics, Biological Research Centre, Hungarian Academy of Sciences, 5 
Temesvári krt. 62, 6726 Szeged, Hungary 6 
2
Institute of Life Sciences, Vasile Goldiş Western University of Arad, Str. Liviu Rebreanu 86, 7 
310414 Arad, Romania 8 
 9 
*
Corresponding author: 10 
Imola Wilhelm M.D., Ph.D. 11 
Institute of Biophysics, Biological Research Centre, Hungarian Academy of Sciences 12 
Temesvári krt. 62, 6726 Szeged, Hungary 13 
Tel: 36-62-599602 14 
Fax: 36-62-433133 15 
E-mail: wilhelm.imola@brc.mta.hu 16 
 17 
Running head: PRRs in the aging brain 18 
  19 
Articles in PresS. Am J Physiol Heart Circ Physiol (August 11, 2017). doi:10.1152/ajpheart.00106.2017 
 Copyright © 2017 by the American Physiological Society.
Abstract 20 
Aging is associated with chronic inflammation (inflamm-aging) partly mediated by increased 21 
levels of damage-associated molecular patterns (DAMPs) which activate pattern recognition 22 
receptors (PRRs) of the innate immune system. Furthermore, many aging-related disorders are 23 
associated with inflammation. PRRs, like Toll-like receptors (TLRs) and NOD-like receptors 24 
(NLRs) are not only expressed in cells of the innate immune system, but other cells as well, 25 
including cells of the neurovascular unit (NVU) and cerebral vasculature forming the blood-26 
brain barrier (BBB). In this review we summarize our current knowledge about the 27 
relationship among activation of PRRs expressed by cells of the NVU/BBB, chronic 28 
inflammation and aging-related pathologies of the brain. The most important DAMP-sensing 29 
PRRs in the brain are TLR2, TLR4, NLRP1 and NLRP3, which are activated during 30 
physiological and pathological aging in microglia, neurons, astrocytes and possibly 31 
endothelial cells and pericytes. 32 
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Introduction 39 
Due to the continuously growing life expectancy, aging and related morbidities are rapidly 40 
increasing unresolved health and socio-economic problems. Cerebrovascular dysfunctions are 41 
common among elderly persons and their incidence increases exponentially with age. The 42 
human brain has a very intense metabolism compared to other organs, by using about 20% of 43 
the body’s resting oxygen consumption and accounting for only 2% of the body weight. 44 
Energy supply of the central nervous system (CNS) is provided by a very dense capillary 45 
system with an average distance of 40-50 µm between neighboring capillaries in the human 46 
brain. This implies that almost all neurons are in the close vicinity of a capillary, so that the 47 
concept of neurovascular unit (NVU) was coined, emphasizing the inseparable character of 48 
neural and vascular functions. Thus, the functional state of the CNS is greatly dependent on 49 
the quality of the microvasculature and the term “you are as old as your arteries” can be 50 
redefined in the brain to “you are as old as your microvessels”. 51 
The neurovascular unit (NVU) in aging 52 
The NVU represents a close structural and functional relationship (i.e. coordinated action) of 53 
microvascular endothelial cells, pericytes, glial cells and neurons (Figure 1). Main functions 54 
of the NVU are formation of the blood-brain barrier (BBB) and neurovascular coupling (i.e. 55 
changes in cerebral blood flow in response to local neural activity). The BBB is a highly 56 
selective permeability barrier that separates the circulating blood from the extracellular fluid 57 
in the CNS. By strictly regulating the molecular and cellular traffic between the blood and the 58 
brain, it substantially contributes to the homeostasis of the CNS (1). The barrier itself is 59 
formed by endothelial cells of the cerebral microvasculature, which acquire special barrier 60 
characteristics in the brain microenvironment. Continuous tight junctions (TJs) 61 
interconnecting cerebral microvascular endothelial cells seal the paracellular cleft, forcing 62 
most molecular and even cellular traffic to use the highly regulated transcellular way of 63 
transport or transmigration. Low level of endocytosis, intracellular enzymes and efflux 64 
transporters of the ATP-binding cassette family also contribute to the barrier (149). By 65 
sharing important regulatory functions, pericytes and astrocytes are also integral parts of the 66 
BBB (3, 137). In the present review we will particularly focus on these three cell types. 67 
There is increasing evidence that dysfunction and senescence of the cerebral microvasculature 68 
play critical roles in age-related brain pathologies. The brain capillary endothelium suffers 69 
region- and species-specific morphological and functional changes during aging, including 70 
elongation, decrease in the number of mitochondria and decrease in choline and glucose 71 
transport (98). In addition, age-related morphological and functional microvascular changes 72 
include fibrosis and degeneration, basement membrane thickening, microhemorrhages, vessel 73 
rarefaction, impaired angiogenesis, dysregulation of cerebral blood flow, lower metabolic 74 
rates of glucose and oxygen and neurovascular uncoupling (17, 27, 45, 143, 144). Reduced 75 
blood flow in aging reflects an impaired vasodilatation and enhanced vasoconstriction (46), 76 
most probably mediated by imbalance in the production of and response to vasoconstrictor 77 
and vasodilator signals (129). After ischemia, inverse neurovascular coupling (i.e. 78 
vasoconstriction instead of vasodilatation) with spreading depolarizations may occur in the 79 
old brain (92). Diminished cerebral blood flow and reduction in functional hyperemia are 80 
largely dependent on loss of pericytes (9). Cerebral endothelial barrier functions can also be 81 
impaired in aging through changes in TJ structure (153). Loss of pericytes (133) might also 82 
contribute to this process. Aging-related BBB breakdown is most evident in the hippocampus, 83 
and is worsening with the appearance of cognitive impairment, that correlates with pericyte 84 
injury and increased levels of soluble PDGFRβ in the cerebrospinal fluid (97). (9). In the 85 
cortex and hippocampus of Alzheimer’s disease (AD) subjects, pericyte number and coverage 86 
are reduced, correlating with BBB breakdown (127). Chronic BBB breakdown leads to 87 
accumulation of neurotoxic serum proteins in the brain tissue contributing to 88 
neurodegeneration. 89 
Altogether, changes in functions of the microvasculature during aging (i.e. neurovascular 90 
uncoupling and alterations in BBB integrity) lead to irreversible neuronal injury. Reductions 91 
in brain microcirculation and BBB breakdown may occur prior to neurodegeneration and 92 
neuroinflammation, as shown in pericyte-deficient mice However, the exact contribution of 93 
microvascular changes to neurodegeneration in aging is not well understood. Nevertheless, 94 
endothelial and glial, but not neuronal-specific genes are the best predictors of biological age 95 
(132). Therefore, the “you are as old as your microvessels” statement refers to the direct link 96 
between vascular and neuronal injury in aging. 97 
Besides endothelial cells and pericytes, astrocytes are also changing during physiological and 98 
pathological aging. The total number of astrocytes in the human brain does not change with 99 
age (121); however, morphological and metabolic remodeling occurs. These changes might be 100 
region specific and might reflect astroglial adaptive plasticity (121). In astrocytes of aged 101 
animals, reduction of gap junction plaques (23), decrease in morphological complexity (32) 102 
and reduction in the ability to support survival of motor neurons (28) were described. 103 
Moreover, astrocytes having a senescence-associated secretory phenotype (SASP) accumulate 104 
with age, showing increased expression of glial fibrillary acidic protein (GFAP) and other 105 
intermediate filaments, secretion of inflammatory cytokines, chemokines and proteinases 106 
(124). 107 
Other cell types of the NVU (neurons and microglia) also present morphological and 108 
functional changes in the elderly (reviewed in: (39)). Moreover, alteration of the structure and 109 
function of the NVU is even more accentuated in pathological aging (39). Unfortunately, 110 
hallmarks of aging are only referring to changes in the phenotypes of cells (86, 99), the 111 
relevance of these changes (i.e. causative or reactive role to aging) is largely uncharacterized. 112 
Inflammation and aging-related functional changes of the NVU 113 
In parallel with these mechanisms, inflammation is a central element affecting cells of the 114 
NVU during aging. Inflammation in the brain has mainly been linked to microglia and to a 115 
lower extent to astrocytes. However, other cells of the NVU are also participating in 116 
inflammatory responses; therefore, might also be key players in aging processes of the CNS. 117 
Vascular inflammation is associated with BBB opening and neurovascular uncoupling, the 118 
main aging-related neurovascular dysfunctions. Inflammation is a well-characterized cause of 119 
BBB disruption (2, 145). Mechanisms of BBB opening may include cytokine-induced actin 120 
remodeling and modulation of TJ protein levels or subcellular relocalization (19). In mice, 121 
during normal aging, reduced amount of TJ proteins and elevated expression of TNF-α has 122 
been observed in CECs, without changes in adhesion molecules and with no leukocyte 123 
recruitment (37), suggesting a direct effect of the cytokine on the amount of TJ proteins. In 124 
aging-related brain pathologies, like AD or ischemia, increased secretion of inflammatory 125 
cytokines in the cerebral endothelium may enhance expression of adhesion molecules as well 126 
(57, 123). Consequent migration of circulating leukocytes through the activated brain 127 
endothelium may also contribute to deterioration in barrier properties of the BBB, which is 128 
also part of the pathogenesis of these diseases (114, 154). Besides increased BBB 129 
permeability, changes in cerebral blood flow and impaired hemodynamic coupling also occur 130 
in response to inflammatory cytokines, like IL-1β (10, 13). Moreover, reactive oxygen species 131 
(ROS) – which are key mediators of both neurovascular uncoupling (141) and of alteration of 132 
the brain endothelial junctional complex in aging (38) – can also trigger secretion of 133 
inflammatory cytokines (102). CECs are rich in mitochondria; therefore, may be important 134 
sources of ROS. Inflammatory cytokines can upregulate ROS generation in CECs leading to 135 
decreased expression of junctional proteins and consequent BBB disruption (120). 136 
Inflammatory vascular dysfunctions not only depend on endothelial but on pericyte- and 137 
astrocyte-linked mechanisms as well. Pericytes respond to inflammatory cytokines through 138 
enhanced expression of adhesion molecules and secretion of inflammatory mediators (106, 139 
111). In addition, astrocytes are a common source of inflammatory mediators in brain 140 
pathologies (43). 141 
Therefore, cells of the NVU can both respond to and release inflammatory mediators, and 142 
vascular inflammation seems to be an important step in aging-related functional changes of 143 
the NVU. In the next chapters, we describe inflammatory aspects of the aging NVU. 144 
Inflammation, damage-associated molecular patterns (DAMPs) and pattern recognition 145 
receptors (PRRs) in aging 146 
Aging is the greatest risk factor for developing chronic diseases, many of which are directly 147 
linked to a persistent low grade inflammation, called inflamm-aging (49). Inflamm-aging is 148 
characterized by a pro-inflammatory environment in several tissues, consisting of activation 149 
of resident macrophages, leukocyte infiltration and increased production of inflammatory 150 
cytokines and ROS. Aging is also associated with the senescence of the immune system, 151 
characterized by loss of naïve T cells, accumulation of memory T cells, thymic involution, 152 
decline in the total number of phagocytes, impairment of dendritic cells and natural killers, 153 
delayed cytokine release, etc. (93, 130), leading to increased frequency of infections and 154 
chronic diseases. 155 
Inflammation is highly regulated by the immune system, which has two main branches, the 156 
innate and the adaptive (acquired) immune system. Initialization of inflammatory processes is 157 
largely dependent on the innate immune system. Sensing of potentially dangerous molecules – 158 
like pathogen-associated molecular patterns (PAMPs) and damage-associated molecular 159 
patterns (DAMPs) – by the innate immune system depends on pattern recognition receptors 160 
(PRRs) consisting of at least four major families (Table 1). Members of the Toll-like receptor 161 
(TLR) and the C-type lectin receptor (CLR) families are membrane-bound PRRs, while 162 
retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) and the nucleotide-binding 163 
oligomerization domain (NOD)-like receptors (NLRs) detect intracellular patterns (91, 138). 164 
Indeed, PAMPs are the most potent activators of these receptors. However, endogenous 165 
molecules released upon tissue damage (DAMPs) can activate the same receptors and 166 
signaling pathways driving a sterile inflammatory reaction. The most widely studied DAMPs 167 
are heat shock proteins, the chromatin protein high mobility group box-1 (HMGB1), 168 
extracellular matrix fragments and purine metabolites, such as ATP and uric acid. DAMP-169 
dependent sterile inflammation is key player in aging-related pathologies (47). Moreover, 170 
DAMPs were proposed to be biomarkers and interventional targets in aging-associated 171 
diseases (70). In elderly, DAMP-induced chronic inflammation is more prevalent than in 172 
young individuals. Chronic oxidative stress is a hallmark of aging and reactive oxygen species 173 
induce oxidative damage leading to formation of DAMPs (38, 125). Accumulation of 174 
crystalline DAMPs, like urate crystals, cholesterol or amyloid deposits may also increase with 175 
age. The most important DAMP-identifying PRRs are TLRs and NLRP3 (47). 176 
Inflammasome activation in aging 177 
Activation of some NLRs leads to the assembly of inflammasomes, which are large 178 
multiprotein complexes mediating activation of inflammatory caspases. The best known 179 
inflammasome-forming NLRs are NLRP1, NLRP3 and NLRC4. Besides, other NLRs might 180 
also form inflammasomes (e.g. NLRP2, NLRP6, NLRP7 or NLRP12). In addition, non-NLR 181 
family members (e.g. AIM2 – absent in melanoma 2, IFI16 – γ-interferon-inducible protein 182 
16 or pyrin) are also inflammasome-forming receptors (15). 183 
Upon recognition of inflammatory signals, inflammasome initiators oligomerize, recruit the 184 
adaptor protein ASC (apoptosis-associated speck-like protein containing CARD) which 185 
interacts with and initiates autoactivation of an inflammatory caspase (caspase-1 or caspase-186 
11/4/5). The active caspase processes precursors of inflammatory cytokines, mainly IL-1β or 187 
IL-18 (7) and can also initiate pyroptosis (15). 188 
Inflammasomes can be activated in response to different PAMPs and DAMPs, the classical 189 
activators being diverse microbial components. NLRP1 inflammasomes assemble upon 190 
stimulation with anthrax lethal toxin or muramyl dipeptide (MDP; a constituent of both Gram-191 
positive and Gram-negative bacteria, sensed by NOD2); the NLRC4 inflammasome is 192 
activated in response to bacterial flagellin sensed by NAIP (NLR family apoptosis inhibitory 193 
protein); pyrin detects RhoA protein inactivated by bacterial toxins, while AIM2 detects 194 
cytosolic microbial or host DNA. Activation of the NLRP3 inflammasome is dependent on 195 
potassium efflux associated with various stimuli including diverse pathogens and several 196 
DAMPs (extracellular ATP, crystalline material, amyloid-β, etc.). Therefore, the NLRP3 197 
inflammasome pathway is one of the most important drivers of sterile inflammatory 198 
processes. 199 
Inflammasomes can play a pivotal role in low-grade chronic inflammation associated with 200 
metabolic abnormalities and aging (i.e. inflamm-aging) as well. Moreover, inflammasome 201 
activation has been linked to diverse brain diseases (including ischemic and traumatic brain 202 
injury and neurodegenerative diseases) and to comorbidities and risk factors of CNS 203 
pathologies (e.g. diabetes, atherosclerosis, obesity, hypertension, etc.) (reviewed in: (74)). 204 
It is well accepted that NLRP3 inflammasome assembly requires two signals: a priming signal 205 
inducing upregulation of the expression of inflammasome components and an activation 206 
signal required for the assembly of the inflammasome (58). It has been suggested that, 207 
although NLRP3 can be activated by a wide variety of pathogens, its primary role is sensing 208 
metabolic disturbance and restoring homeostasis. However, chronic metabolic dysfunction in 209 
aging might result in aberrant NLRP3 response, leading to aging-associated inflammatory 210 
disorders (21). In the absence of PAMPs, elevated levels of TNF-α (110) seem to be one of 211 
the major inducers of NLRP3 expression in macrophages of the liver and in adipose tissue in 212 
aged mice (8). Nevertheless, NLRP3 inflammasome is involved in the induction of obesity 213 
and insulin resistance (135), conditions linked to aging and risk factors for brain disease. 214 
PRRs and inflammasome activation in the aging brain 215 
Inflamm-aging and immune senescence substantially affect the CNS (31). The low-grade 216 
inflammatory status of the aged CNS is associated with recruitment of leukocytes, i.e. 217 
dendritic cells and T cells, including memory CD8 T cells (119, 134). The majority of CNS 218 
diseases, including age-related pathological conditions, are characterized by 219 
neuroinflammatory processes (117). These pathological conditions include neurodegenerative 220 
disorders (50), like AD (113), Huntington’s disease (96), Parkinson’s disease (PD) (68), 221 
amyotrophic lateral sclerosis (ALS) (151) or multiple sclerosis (MS) (52). In addition, 222 
inflammation has been identified as an important player in cognitive dysfunctions (109), 223 
memory loss (64) and cerebral ischemia as well (147). A significant part of these disorders is 224 
age-related. 225 
Activation of PRRs and of inflammasomes is an important event in these pathologies (Table 226 
2) as a non-specific neuroinflammatory event (82). Aging was shown to induce upregulation 227 
of TLR1, TLR2, TLR4, TLR5 and TLR7 and downregulation of TLR9 expression in the 228 
mouse brain, while TLR3, TLR6 and TLR8 remain unchanged (81). Interestingly, 229 
upregulation of innate immune system-specific genes (complement genes; TLRs: TLR2, 230 
TLR4, TLR5; inflammasome-associated genes: caspase-1, IL-18 and IL-1β) in the human 231 
brain is more robust during normal aging than in AD (25). 232 
Among cells of the CNS, microglia, the resident innate immune cells of the CNS, express the 233 
most PRRs, including a complex set of TLRs (TLR1-9) (75). Activation of TLR2, TLR4 and 234 
TLR9 in microglia can lead to an inflammatory response resulting in neuronal damage (122). 235 
Activation of microglial TLR2 and TLR4 receptors enhances microglial phagocytosis of 236 
neurons contributing substantially to neuronal loss during brain inflammation (105). TLR2 is 237 
involved in microglial activation in chronic neurodegenerative diseases such as AD and PD 238 
(63). In AD, TLR2, TLR4 and other TLRs expressed in microglial cells are involved in 239 
phagocytosis of amyloid-β in the early stages and contribute to neuroinflammatory responses 240 
in the late stages (54). Physiological aging is associated with an increased microglial response 241 
to LPS. However, in AD, TLR4 signaling is diminished contributing to the accumulation of 242 
amyloid-β in the brain (55). Similarly, cultured senescent microglial cells show decreased 243 
expression of TLR2 and TLR4 and reduced capacity to migrate and phagocytize (18). In 244 
contrast, upregulation of TLR4 was observed in microglial cells in the forebrain of 245 
postmenopausal women (126). In addition, TLR4 localized to microglia plays a role in 246 
ischemic brain injury (71). 247 
Microglia express several inflammasome components as well, including inflammasome-248 
forming NLRs, AIM2, the adaptor protein ASC and inflammatory caspases and can secrete 249 
active IL-1β through inflammasome-dependent and -independent mechanisms (16). 250 
Activation of NLRP3 inflammasome in microglial cells has been shown to be involved in the 251 
pathogenesis of AD (65). A proposed mechanism is that microglia phagocytize fibrillar 252 
amyloid-β, leading to lysosomal damage and release of cathepsin B from damaged lysosomes 253 
into the cytoplasm. Cathepsin B activates the NLRP3 inflammasome resulting in IL-1β 254 
release (62). Interestingly, only microglia isolated from aged mouse brains secrete IL-1β in 255 
response to fibrillar amyloid-β, while microglia isolated from young adult mouse brains do 256 
not, indicating the primed state of microglial inflammasomes in aged animals (152). Age-257 
associated priming of microglia can be induced by activation of the peripheral innate immune 258 
system (e.g. as a result of systemic infections) and plays a central role in exaggerated 259 
neuroinflammation (67). 260 
In contrast to the well-accepted role of microglia in inflammatory processes of the aging 261 
brain, a recent study suggests that aging-induced upregulation of PRRs in cerebellar and 262 
hypothalamic brain regions does not primarily localize to microglia (11). 263 
Neurons also express TLRs which may be involved in age-related pathologies (77, 108). 264 
TLR2 expression is significantly increased in PD brain neurons and is localized to α-265 
synuclein positive Lewy bodies (36). Moreover, TLR signaling in sensory neurons contributes 266 
to persistent pain and neuroinflammation (85). TLR2 and TLR4 expression increases in 267 
cerebral cortical neurons in response to ischemia/reperfusion contributing to neurological 268 
deficits (140). TLR3, on the other hand, impairs working memory and inhibits hippocampal 269 
neurogenesis (107). 270 
Neurons express diverse NLRs as well and are able to form functional NLRP1, NLRP3, 271 
NLRC4 and AIM2 inflammasomes (4, 74, 148). Aging-induced NLRP1 inflammasome 272 
activation in hippocampal neurons was shown to be involved in cognitive impairment (90). In 273 
AD, NLRP1 is upregulated in neurons (74) resulting in activation of the pyroptotic pathway, 274 
contributing to cognitive decline (139). In addition, NLRP1 and NLRP3 inflammasomes play 275 
a major role in neuronal cell death in stroke (42). 276 
Besides microglia and neurons, other cell types of the NVU can also take part in aging-related 277 
neuroinflammation. Cells of the BBB (endothelial cells, pericytes and astrocytes) express 278 
different PRRs and inflammasome components (Figure 1) which may have an important role 279 
in inflammatory processes. Inflammation and related oxidative stress, developing naturally in 280 
aging, are important mechanisms of cerebrovascular malfunction. Moreover, inflammatory 281 
mechanisms of the vasculature seem to be common and increasingly important in 282 
neurological disorders (80). 283 
Role of PRR and inflammasome activation in cells of the BBB 284 
Brain endothelial cells are critical in regulating the communication between the immune and 285 
central nervous systems (6), equipped with a whole set of signaling molecules (40, 44, 150). 286 
They are the first cells of the NVU coming in contact with circulating pathogens, activated 287 
immune cells and cytokines. Moreover, brain endothelial cells are essential in activating the 288 
hypothalamic-pituitary-adrenal inhibitory feedback in systemic inflammation (56). The key 289 
role of the BBB as a link between neuroinflammation and neurodegeneration has been 290 
increasingly recognized (59, 80). 291 
Cerebral endothelial cells have been shown to express a whole set of TLRs including TLR2, 292 
TLR3, TLR4, TLR6 and TLR9 (22, 101), and these receptors have been shown to participate 293 
in important signaling processes. Besides TLR4, TLR2 is the main sensor of bacterial 294 
infections in brain endothelial cells (22, 76), while TLR3 responds to double stranded RNA 295 
with cytokine release (48, 83). Activation of TLR4 or TLR2/6 leads to an increased BBB 296 
permeability (101, 146). 297 
Although brain endothelial TLRs have not been directly linked to physiological or 298 
pathological aging so far, TLR4/MyD88/NF-κB signaling in endothelial cells of the BBB is 299 
central in the regulation of both pro- and anti-inflammatory mechanisms, which have a key 300 
role in aging. Moreover, oxidative stress upregulates expression of TLR2, TLR3, TLR4 and 301 
TLR6 in vitro (101). In addition, ischemic stroke-induced fibrin deposition triggers TLR2 and 302 
TLR4 expression and activation in the cerebral vasculature of aged rats (155). In this process, 303 
both endothelial cells and pericytes are probably involved. Besides fibrin and fibrinogen, 304 
Hsp60 is another potential endogenous ligand for TLR2 and TLR4 in ischemia (14). 305 
Nevertheless, using preconditioning with TLR2 or TLR4 ligands, tolerance to cerebral 306 
ischemia, maintenance of microvascular patency and attenuation of BBB disruption can be 307 
achieved (29, 69). In addition, increased TLR4 expression in brain endothelial cells can 308 
contribute to astrocyte swelling and brain edema formation (73). 309 
TLR4 can be primarily activated by PAMPs, e.g. LPS and other pathogenic components. The 310 
envelope protein of MSRV (multiple sclerosis-associated retrovirus), a virus found in most 311 
patients with MS, is recognized by cerebral endothelial TLR4 and induces ICAM-1 312 
overexpression, production of IL-6 and IL-8 and immune cell transmigration (35). Therefore, 313 
MSRV can maintain chronic inflammation through TLR4 activation. TLR4-dependent 314 
activation of ICAM-1 and of the inflammatory phenotype of brain endothelial cells has been 315 
proved in other studies as well (20, 78, 128). As a consequence, endothelial TLR4 has a 316 
decisive role in neuroinflammation through leukocyte recruitment into CNS (156). On the 317 
other hand, cerebral endothelial cells, and not perivascular microglia, are the main targets of 318 
circulating inflammatory mediators to activate brain circuits regulating release of anti-319 
inflammatory glucocorticoids (56). 320 
Regarding NLR expression and activation, experimental studies were mainly performed in 321 
non-cerebral endothelial cells. In a recent study (100), we detected expression of several 322 
NLRs – including NOD1, NOD2, NLRC4, NLRC5, NLRP1, NLRP3, NLRP5, NLRP9, 323 
NLRP10, NLRP12, NLRA and NLRX – in human brain endothelial cells. We have also 324 
shown that NLRP3 expression can be significantly induced by inflammatory stimuli. 325 
Expression of key inflammasome components (NOD2, NLRP3 and caspase-1) along with 326 
caspase-cleaved interleukins IL-1β and IL-33 can be induced by priming with LPS and 327 
activation with MDP. In addition, combining priming and activation of brain endothelial 328 
inflammasomes results in active IL-1β secretion. Since this is a recently described 329 
mechanism, further studies are needed to understand the role of brain endothelial 330 
inflammasome activation in pathological processes of the CNS, including aging-related 331 
diseases. Nevertheless, NLRP3 activation has been shown to mediate endothelial senescence 332 
in non-cerebral endothelial cells (136), indicating that inflammasome activation might have 333 
an important role in aging and aging-related disorders, possibly both inside and outside the 334 
CNS. 335 
Even much less is known about the expression and role of PRRs in cerebral pericytes. 336 
Besides TLR4, NOD1 and NOD2 (60, 104), we have recently shown the expression of TLR2, 337 
TLR5, TLR6, TLR10, NLRC5, NLRP1-3, NLRP5, NLRP9, NLRP10 and NLRX mRNA in 338 
cultured brain pericytes (106). TLR4 expressed in brain pericytes can not only respond to 339 
LPS, but to HMGB1 as well (60), suggesting the role of this receptor in sterile inflammation. 340 
In addition, TLR2 expression in the post-ischemic vasculature of aged rats was shown to 341 
partly co-localize with the pericyte marker PDGFRβ (155). Further investigations are needed 342 
to understand the role of PRRs expressed in pericytes in aging-related pathologies of the 343 
brain. Nevertheless, pericytes have a complex immunological role by secreting diverse 344 
chemokines and cytokines, expression of adhesion molecules and controlling immune cell 345 
trafficking (103). Moreover, inflammatory stimuli and oxidative stress – which can be aging-346 
associated alterations – upregulate several PRRs in pericytes, although cannot activate 347 
inflammasomes (106). 348 
Among cells of the BBB, astrocytes may have the most important role in sterile inflammatory 349 
reactions of the brain. Besides microgliosis, chronic neurodegeneration is characterized by 350 
astrogliosis as well, and both microglia and astrocytes can extensively respond to and release 351 
cytokines on this background (66). Moreover, these two cell types extensively cross-talk with 352 
cells of the adaptive and innate immune system infiltrating the CNS (116). 353 
Astrocytes express several TLRs on the mRNA and protein level; however, their TLR 354 
expression profile is more limited in vivo than in vitro (77). Expression level of TLRs (TLR2, 355 
TLR3 and TLR4) is lower in astrocytes than in microglia, and astrocytes may respond more 356 
robustly to TLR2/3/4 agonists in the presence of microglia (89). Moreover, TLR2/3/4 agonists 357 
are able to prime microglia but not astrocytes for ATP-dependent IL-1β release (41). In line 358 
with this observation, in animals with chronic neurodegenerative prion disease, IL-1β 359 
synthesis in response to IL-1β or TNF-α occurs exclusively in microglia and not in astrocytes 360 
(66). On the other hand, α-synuclein can activate proinflammatory TLR4 pathways in primary 361 
astrocytes (115). 362 
Astrocyte-expressed TLRs, together with RLRs, can be involved in the antiviral response and 363 
type I IFN secretion. Viruses infecting and replicating in neurons (e.g. rabies virus or 364 
vesicular stomatitis virus) can abortively infect astrocytes, which have a decisive role in 365 
antiviral protection of the CNS (53, 112). Not only RNA viruses, but DNA viruses (e.g. 366 
herpes simplex virus-1) are also sensed in a RIG-I-dependent manner by astrocytes (26). 367 
Astrocytic RLRs (RIG-I, MDA5) are not only involved in anti-viral immune responses, but in 368 
type I IFN release after spinal cord injury and cerebral ischemia (12, 30), supporting the idea 369 
that astrocytes and RLRs contribute to several inflammatory processes in different CNS 370 
diseases. 371 
In addition, astrocytes express several NLRs and are able to activate inflammasomes. 372 
Cultured cortical astrocytes express NLRP1, NLRP3, NLRC4 and AIM2, among which 373 
NLRP3 mRNA is the most abundant (5). Induction of NLRP1, NLRP3 and IL-1β in both 374 
neurons and astrocytes was shown to contribute to ethanol-dependent impairment in 375 
neurogenesis (157). In addition, NLRP3 inflammasome activation in astrocytes might be 376 
involved in the pathogenesis of PD (87). Aberrant NLRP3 activation was described in 377 
glioblastoma cells (142). However, no IL-1β or IL-18 secretion could be detected in 378 
microglia-free astrocyte cultures in response to cytokine priming and the NLRP3 activators 379 
ATP, nigericin, amyloid-β or α-synuclein (61). Others observed inflammasome-dependent 380 
production of IL-1β in response to LPS/amyloid-β; however, in this case microglial 381 
contamination was not unambiguously excluded (24). On the other hand, inflammatory 382 
activation of brain endothelial cells in neurobrucellosis was shown to partly depend on IL-1β 383 
secreted by both microglia and astrocytes in a TLR2-, NLRP3- and AIM2-dependent manner 384 
(95). 385 
Astrocytes can activate NLRC4 inflammasomes as well, and resulting IL-1β is involved in 386 
enhancing amyloid-β levels in neurons. This suggests an involvement of NLRC4 387 
inflammasome in astrocytes in inflammatory responses associated with AD (84). Moreover, 388 
the functional NLRP2 inflammasome – consisting of NLRP2, ASC and caspase-1 – was first 389 
described in astrocytes. NLRP2 inflammasome in astrocytes is preassembled into a 390 
multiprotein complex with the pannexin 1 channel and the P2X7 receptor, does not require 391 
priming, is activated by extracellular ATP and contributes to the maturation of IL-1β and IL-392 
18 (94). This suggests that NLRP2 – similarly to NLRP3 – can detect DAMPs released during 393 
injury. However, the role of NLRP2 inflammasome in pathological processes has not been 394 
evaluated so far. 395 
Conclusions and possible future directions 396 
Aging and aging-related CNS pathologies are accompanied by chronic sterile inflammation 397 
(inflamm-aging) which is largely determined by activation of pattern recognition receptors 398 
(PRRs), like TLR2, TLR4 or NLRP3 (Figure 2). These react to DAMPs (damage-associated 399 
molecular patterns) – i.e. self-molecules released upon cellular stress, tissue injury and 400 
necrosis – which accumulate during life. Due to age-dependent increase in cytokine 401 
production of senescent cells, PRRs and inflammasome components can be in a primed state 402 
in elderly. Therefore, inflammasome-activating signals (e.g. amyloid-β fibrils in AD or ROS 403 
released upon ischemia-reoxygenation) can directly lead to cytokine (IL-1β or IL-18) release 404 
and pyroptotic cell death. 405 
Inflammatory reactions in the aging brain have mainly been linked to microglia and to a lower 406 
extent to astrocytes and neurons. Recently, CECs and pericytes have also been shown to 407 
express PRRs and to release inflammatory cytokines. Since the vasculature is largely involved 408 
in aging-related disorders, inflammatory reactions of the BBB might be involved in the 409 
pathomechanism of these conditions. It is our hope that further studies will elucidate the exact 410 
role of cells of the cerebral vasculature in inflammatory reactions of the aging brain. In 411 
addition, possible existence of any links between activation of PRRs and age-related BBB 412 
disruption or uncoupling of functional hyperemia also need to be clarified. Moreover, it would 413 
be important to understand whether changes in the functions of cells of the NVU are causes or 414 
compensatory consequences of aging. 415 
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Tables 913 
Table 1. 914 
Pattern recognition receptors (PRRs) 
Best 
characterized 
members 
Best known activators 
References 
PAMPs DAMPs 
Membrane-
bound PRRs 
Toll-like 
recepors 
(TLRs) 
TLR1-10 
(human)    
 
  
TLR2 
bacterial 
lipoproteins 
Hsp60, 
Hsp70, 
HMGB1, fibrin 
(47, 79, 
138) 
  
TLR3 
double-
stranded RNA 
endogenous 
nucleic acids 
  
TLR4 LPS 
Hsp60, 
Hsp70, 
HMGB1, fibrin 
  
TLR5 flagellin 
 
  
TLR9 
unmethylated 
CpG 
endogenous 
nucleic acids 
C-type 
lectin 
receptors 
(CLRs) 
    
 
  
mannose 
receptor 1 
repeated 
mannose 
units 
endogenous 
glycoproteins 
(138) 
  
mincle 
bacterial 
glycolipids 
spliceosome-
associated 
protein 130 
  
dectin-1 
glucans from 
fungi 
endogenous 
glycoproteins 
Cytoplasmic 
PRRs 
NOD-like 
receptors 
(NLRs) 
NLRA 
(CIITA), 
NLRB 
(NAIP), 
NOD1, 
NOD2, 
NLRC3-5, 
NLRP1-
14, NLRX 
   
 
  
NOD2 MDP 
 
(100, 138) 
  
NLRC4 flagellin 
 
(15) 
  
NLRP1 
MDP, anthrax 
lethal toxin  
(15) 
  
NLRP3 
MDP, 
nigericin 
ROS, 
amyloid-β 
fibrils, ATP, 
uric acid 
(15, 47, 61, 
100) 
RIG-I-like 
receptors 
(RLRs) 
    
 
  
RIG-I 
viral double 
stranded RNA  
(138) 
  
MDA-5 
viral double 
stranded RNA  
 915 
Table 2. 916 
Pattern 
recognition 
receptor 
Cell or tissue 
Regulation or 
function 
Remarks Reference 
TLR2 
mouse brain 
(mononuclear 
phagocytes) 
mRNA ↑ in aging 
 
(82) 
mouse brain  
mRNA ↑ in plaque-
associated brain tissue 
of AD model mice 
 
(51) 
human brain 
(hippocampus, 
entorhinal cortex, 
superior frontal gyrus, 
post-central gyrus) 
mRNA ↑ in aging and 
AD 
modest ↑ in AD 
relative to the aged 
brain which shows 
robust ↑ compared to 
young 
(25) 
rat hippocampus 
(microglia) 
mRNA ↑ in 
postoperative 
cognitive dysfunction 
in senile animals 
 
(88) 
mouse microglia 
involved in both 
amyloid-β uptake and 
inflammatory cytokine 
production 
 
(72) 
human brain 
(neurons) 
protein ↑ in PD 
 
(36) 
neurons (mouse 
cortex) 
protein ↑, proapoptotic 
in ischemia  
(140) 
rat brain (vasculature) 
protein ↑, activation in 
ischemic stroke  
(155) 
TLR4 
mouse brain mRNA ↑ in aging 
 
(82) 
mouse brain  
mRNA ↑ in plaque-
associated brain tissue 
of AD model mice 
 
(51) 
human brain 
(hippocampus, 
superior frontal gyrus, 
post-central gyrus) 
mRNA ↑ in aging and 
AD 
modest ↑ in AD 
relative to the aged 
brain which shows 
robust ↑ compared to 
young 
(25) 
mouse microglia 
involved in both 
amyloid-β uptake and 
inflammatory cytokine 
production 
 
(118, 131) 
microglia (mouse 
striatum) 
TLR4 knockout: 
neuroprotective in 
ischemia 
 
(71) 
neurons (mouse 
cortex) 
protein ↑, proapoptotic 
in ischemia  
(140) 
rat brain (vasculature) 
protein ↑, activation in 
ischemic stroke  
(155) 
primary mouse 
astrocytes 
activation in response 
to α-synuclein  
(115) 
other TLRs 
mouse brain 
TLR1,TLR5, TLR7 
mRNA ↑ in aging  
(82) 
mouse brain 
TLR9 mRNA ↓ in 
aging  
(82) 
mouse brain 
TLR5, TLR7, TLR9 
mRNA ↑ in plaque-
associated brain tissue 
of AD model mice 
 
(51) 
mouse hippocampus 
TLR3: suppression of 
neural plasticity and 
inhibition of memory 
retention 
 
(107) 
mouse microglia 
TLR9: involved in 
amyloid-β uptake  
(33, 34) 
NLRP1 
rat hippocampus 
NLRP1 inflammasome 
activation in aging  
(90) 
human hippocampus 
(neurons); mouse 
models of AD 
protein ↑ in AD, role in 
neuronal pyroptosis 
and cognitive 
impairment 
 
(74, 139) 
mouse cortical 
neurons (cell culture, 
stroke model), human 
brain 
protein ↑ in 
ischemia/reperfusion, 
role in neuronal cell 
death and behavioral 
deficits 
 
(42) 
NLRP3 
mouse microglia 
NLRP3 inflammasome 
activation in AD 
models 
only microglia isolated 
from aged mouse 
brains secrete IL-1β 
in response to fibrillar 
amyloid-β 
(62, 65, 
152) 
mouse cortical 
neurons (cell culture, 
stroke model), human 
brain 
protein ↑ in 
ischemia/reperfusion, 
role in neuronal cell 
death and behavioral 
deficits 
 
(42) 
rat primary astrocytes, 
mouse substantia 
nigra 
protein ↑, activation of 
NLRP3 inflammasome 
in PD models 
 
(87) 
other 
inflammasome 
components 
human brain 
(hippocampus) 
caspase-1, IL-1β, IL-
18 mRNA ↑ in aging 
and AD 
modest ↑ in AD 
relative to the aged 
brain which shows 
robust ↑ compared to 
young 
(25) 
rat hippocampus 
(neurons) 
caspase-1, P2X7 
receptor, pannexin-1 
protein (involved in 
NLRP1 and NLRP3 
inflammasome 
activation) ↑ in aging 
 
(90) 
mouse cortical 
neurons (cell culture, 
stroke model), human 
brain 
 ASC, caspase-1 (pro- 
and active form), IL-1β  
(pro- and active form), 
IL-18  (pro- and active 
form) protein ↑ in 
ischemia/reperfusion 
 
(42) 
rat primary astrocytes, 
mouse substantia 
nigra 
caspase-1, IL-1β (pro- 
and active form) 
protein ↑ in PD models 
 
(87) 
primary rat astrocytes, 
human neocortex 
NLRC4 inflammasome 
activation in 
astrocytes: ↑ amyloid-
β levels in neurons; 
NLRC4, ASC protein ↑ 
in sporadic AD 
 
(84) 
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